Transmembrane and Juxtamembrane Domain Mutations Activate HER2

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-192
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Actionable Activating Oncogenic ERRB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Transmembrane and Juxtamembrane Structure of αL Integrin in Bicelles

PLoS ONE
Multidisciplinary
2013English

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Mutations That Bypass tRNA Binding Activate the Intrinsically Defective Kinase Domain in GCN2

Genes and Development
GeneticsDevelopmental Biology
2002English

A Novel Juxtamembrane Domain Isoform of HER4/ErbB4

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Autoinhibition of the Ron Receptor Tyrosine Kinase by the Juxtamembrane Domain

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2014English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

The Role of Palmitoylation and Transmembrane Domain in Sorting of Transmembrane Adaptor Proteins

Journal of Cell Science
Cell Biology
2015English

P2.13-46 Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy